{"id":8600,"date":"2022-01-19T09:47:06","date_gmt":"2022-01-19T08:47:06","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=8600"},"modified":"2022-01-19T09:47:41","modified_gmt":"2022-01-19T08:47:41","slug":"jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/en\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/","title":{"rendered":"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited"},"content":{"rendered":"<p>\u201cWe are clearly excited about our new partnership with Peijia Medical and the opportunity to bring our innovative TAVR technology to potentially millions of patients in China.,\u201d said John Kilcoyne, JenaValve\u2019s CEO. \u201cThe capital raised associated with this partnership provides JenaValve additional funding to suppport our ALIGN-AR PMA clinical trial, as well as our strategy to accelerate expansion of our current commercial activities in Europe. I am pleased to say, that following IDE approval of the ALIGN-AR Trial in August 2021, patient enrollent remains on track as we diligently work to achieve our ultimate goal of receiving U.S. FDA approval for the Trilogy Heart Valve System.\u201d<\/p>\n<p>\u201cWith the addition of the TrilogyTM, Peijia will have a more comprehensive product portfolio to better serve patients with aortic valve diseases in China,\u201d said Dr. Yi Zhang, Peijia\u2019s Chairman and Chief Executive Officer. \u201cCurrently, there are no transfemoral TAVR devices approved for aortic regurgitation in China; however, some patients with severe aortic regurgitation have to be treated by off-label use of TAVR devices as they are not eligible for open heart surgery. The Trilogy TM System provides a new treatment option to doctors and brings hope to aortic regurgitation patients. The investment in and collaboration with JenaValve solidifies Peijia\u2019s commitment and market-leading position in the structural heart field in China,\u201d said Dr. Yi Zhang.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cWe are clearly excited about our new partnership with Peijia Medical and the opportunity to bring our innovative TAVR technology to potentially millions of patients in China.,\u201d said John Kilcoyne, JenaValve\u2019s CEO. \u201cThe capital raised associated with this partnership provides JenaValve additional funding to suppport our ALIGN-AR PMA clinical trial, as well as our strategy&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[123],"class_list":["post-8600","post","type-post","status-publish","format-standard","hentry","category-biodiscovery-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"\u201cWe are clearly excited about our new partnership with Peijia Medical and the opportunity to bring our innovative TAVR technology to potentially millions of patients in China.,\u201d said John Kilcoyne, JenaValve\u2019s CEO. \u201cThe capital raised associated with this partnership provides JenaValve additional funding to suppport our ALIGN-AR PMA clinical trial, as well as our strategy...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-19T08:47:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-19T08:47:41+00:00\" \/>\n<meta name=\"author\" content=\"Nicolas Delsert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Delsert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/\"},\"author\":{\"name\":\"Nicolas Delsert\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\"},\"headline\":\"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited\",\"datePublished\":\"2022-01-19T08:47:06+00:00\",\"dateModified\":\"2022-01-19T08:47:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/\"},\"wordCount\":235,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"articleSection\":[\"andera Life Sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/\",\"name\":\"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"datePublished\":\"2022-01-19T08:47:06+00:00\",\"dateModified\":\"2022-01-19T08:47:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.anderapartners.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\",\"name\":\"Nicolas Delsert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"caption\":\"Nicolas Delsert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/","og_locale":"en_US","og_type":"article","og_title":"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited - ANDERA PARTNERS","og_description":"\u201cWe are clearly excited about our new partnership with Peijia Medical and the opportunity to bring our innovative TAVR technology to potentially millions of patients in China.,\u201d said John Kilcoyne, JenaValve\u2019s CEO. \u201cThe capital raised associated with this partnership provides JenaValve additional funding to suppport our ALIGN-AR PMA clinical trial, as well as our strategy...","og_url":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2022-01-19T08:47:06+00:00","article_modified_time":"2022-01-19T08:47:41+00:00","author":"Nicolas Delsert","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicolas Delsert","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/"},"author":{"name":"Nicolas Delsert","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c"},"headline":"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited","datePublished":"2022-01-19T08:47:06+00:00","dateModified":"2022-01-19T08:47:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/"},"wordCount":235,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"articleSection":["andera Life Sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/","url":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/","name":"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"datePublished":"2022-01-19T08:47:06+00:00","dateModified":"2022-01-19T08:47:41+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/fr\/jenavalve-announces-strategic-investment-and-licensing-agreement-with-peijia-medical-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.anderapartners.com\/en\/"},{"@type":"ListItem","position":2,"name":"JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited"}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c","name":"Nicolas Delsert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","caption":"Nicolas Delsert"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/8600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/comments?post=8600"}],"version-history":[{"count":0,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/8600\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media?parent=8600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/categories?post=8600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}